A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2004
12/08/2004	EP1483257A1 Quinazoline compounds useful in therapy
12/08/2004	EP1483247A2 Aryl substituted pyrimidines and the use thereof
12/08/2004	EP1483244A1 Cyclic n-substituted alpha iminocarboxylic acids for selectively inhibiting collagenase
12/08/2004	EP1483239A2 Indole-amide derivatives and their use as glycogen phosphorylase inhibitors
12/08/2004	EP1483237A2 Tropane compounds
12/08/2004	EP1483231A1 Novel cinnamate salts, method for production and use thereof as medicaments
12/08/2004	EP1483228A1 Nk1 antagonists
12/08/2004	EP1482988A1 METHOD OF RADIO−LABELLING BIOMOLECULES
12/08/2004	EP1482983A2 Non-myeloablative tolerogenic treatment with tyrphostins
12/08/2004	EP1482976A1 A preparation and method for weight reduction
12/08/2004	EP1482973A1 Methods of modulating cd200 receptors
12/08/2004	EP1482970A1 Cancer therapy
12/08/2004	EP1482968A2 Treatment of type i diabetes mellitus using growth hormone antagonist
12/08/2004	EP1482967A1 Pharmaceutical and cosmetic compositions comprising plgf-1
12/08/2004	EP1482962A2 Method of treating trx mediated diseases
12/08/2004	EP1482954A2 Alpha-substituted arylalkyl phosphonate derivatives
12/08/2004	EP1482949A1 Sulfatase inhibiting progestogen-only contraceptive regimens
12/08/2004	EP1482948A1 Continuous sulfatase inhibiting progestogen hormone replacement therapy
12/08/2004	EP1482947A1 Extended cycle estrogen and sulfatase inhibiting progestogen contraceptive regimens
12/08/2004	EP1482941A1 Beta-sheet mimetics and composition and methods relating thereto
12/08/2004	EP1482940A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
12/08/2004	EP1482938A1 Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist
12/08/2004	EP1482937A2 Novel tyloindicines and related processes, pharmaceutical compositions and methods
12/08/2004	EP1482936A1 Ophthalmic composition comprising ascomycin
12/08/2004	EP1482935A1 Thiazole and oxazole derivatives which modulate ppar activity
12/08/2004	EP1482933A2 Potent, simplified derivatives of immunosuppressive agents
12/08/2004	EP1482932A1 N3 alkylated benzimidazole derivatives as mek inhibitors
12/08/2004	EP1482931A2 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/08/2004	EP1482929A1 Use of substituted 3-phenyl-5-alkoxy-1,3,4-oxdiazole-2-one for producing medicaments that inhibit pancreatic lipase
12/08/2004	EP1482926A2 Amino-methyl substituted tetracycline compounds
12/08/2004	EP1482925A1 5-(2-hydroxy-3-'1-(3-trifluoromethylphenyl)-cyclopropl!-propionylamino)-phtalide and related compounds with progesterone receptor modulating activity for use in fertility control and hormone replacement therapy
12/08/2004	EP1482924A2 Cathepsin cysteine protease inhibitors
12/08/2004	EP1482916A2 Schwann cell and phosphodiesterase inhibitors based therapy
12/08/2004	EP1482895A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004	EP1482795A1 New immunoeffector compounds
12/08/2004	EP1436283A4 Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof
12/08/2004	EP1434886A4 Mid 241 receptor, a novel g-protein coupled receptor
12/08/2004	EP1381363B1 Imidazo [1,2-a]-pyridine derivatives as mglur5 antagonists
12/08/2004	EP1363898A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/08/2004	EP1341754B1 Substituted anthranilic acids
12/08/2004	EP1303290A4 Small peptides and methods for downregulation of ige
12/08/2004	EP1252155B1 Ethanol solvate of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8- [4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one
12/08/2004	EP1240152B1 Ox(adi)azolyl-hydroxamic acids useful as procollagen c-proteinase inhibitors
12/08/2004	EP1233787B1 Product inhibiting transduction of g heterotrimeric protein signals combined with another anti-cancer agent for therapeutic use in cancer treatment
12/08/2004	EP1220856B1 Pyrazolo[4,3-d]pyrimidine derivatives
12/08/2004	EP1220669A4 Therapeutic intervention to mimic the effect of caloric restriction
12/08/2004	EP1127052B1 Substituted 2-phenylbenzimidazoles, the production thereof and their use
12/08/2004	EP1121369B1 Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection
12/08/2004	EP1119548B1 3-(3-chloro-4-hydroxyphenylamino)-4-(2-nitrophenyl)-1h-pyrrole-2,5-dione as glycogen synthase kinase-3 inhibitor (gsk-3)
12/08/2004	EP1027062B1 Germicidal compositions for the treatment of animal infectious diseases of the hoof, comprising a copper salt, a quaternary ammonium compound and a peroxide
12/08/2004	EP1015015A4 pRb2/p130 PEPTIDE INHIBITORS OF cdk2 KINASE ACTIVITY
12/08/2004	EP1014999B1 Cationic polymers as toxin-binding agents
12/08/2004	EP0952836B1 Use of sulphoquinovosyldiacylglycerols for the treatment of inflammatory skin diseases
12/08/2004	EP0812190B1 R-enantiomer of n-propargyl-1-aminoindan for the treatment of various diseases and mesylate, esylate and sulfate thereof
12/08/2004	CN1553961A Membrane virus host range mutations and their uses as vaccine substrates
12/08/2004	CN1553952A Materials and methods to promote repair of nerve tissue
12/08/2004	CN1553951A Human cord blood derived unrestricted somatic stem cells (USSC)
12/08/2004	CN1553916A Heteroaryl substituted fused bicyclic heteroaryl compounds as GABAA receptor ligands
12/08/2004	CN1553915A Method for the preparation of hexahydro-furo-[2,3-b]furan-3-ol
12/08/2004	CN1553910A Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
12/08/2004	CN1553905A Novel urea compounds as vanilloid receptor antagonist for treatment of pains
12/08/2004	CN1553901A New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds
12/08/2004	CN1553900A Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
12/08/2004	CN1553895A Taxol enhancer compounds
12/08/2004	CN1553814A Remedies for arteriosclerosis
12/08/2004	CN1553808A Use of HCG in controlled ovarian hyperstimulation
12/08/2004	CN1553806A Use of SAPR-1 for the treatment and/or prevention of scleroderma
12/08/2004	CN1553804A Combinations for the treatment of inflammatory disorders
12/08/2004	CN1553801A Inhalation compositions comprising tricyclic 5,6-dihydro-9H-pyrazolo (3,4-C)-1,2,4-triazolo (4,3-alpha) pyridines
12/08/2004	CN1553800A Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders
12/08/2004	CN1553798A Modifying the fatty acid composition of cell membranes of organs and tissues
12/08/2004	CN1553797A Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof
12/08/2004	CN1553794A Stable skin conditioning compositions containing retinoid boosters
12/08/2004	CN1553793A Hair follicle neogenesis by injection of follicle progenitor cells
12/08/2004	CN1552892A Physiological active buck peptide by compound proteinase catalysis and use of products thereby
12/08/2004	CN1552855A Vascular endothelial growth factor 2
12/08/2004	CN1552474A Medicine coating rack
12/08/2004	CN1552436A Medicine for treating cerebral abnormality
12/08/2004	CN1552429A Chinese medicine preparation for treating senility disease
12/08/2004	CN1552328A Use of phenoxthine compounds in preparing medicnies for inhibiting cancers and promoting radio-sensitive medicines
12/08/2004	CN1552315A 治疗组合物 The therapeutic composition
12/08/2004	CN1179041C Improved phytases
12/08/2004	CN1178950C Corpuscles of stannius protein and stanniocalcin
12/08/2004	CN1178941C CRF receptor antagonists and method relating thereof
12/08/2004	CN1178940C Selective antagonists of A28 adenosine receptors
12/08/2004	CN1178939C Non-nucleoside reverse transcriptase inhibitors
12/08/2004	CN1178936C Sulfonyl-pyrrolidine derivatives
12/08/2004	CN1178935C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
12/08/2004	CN1178932C Amide derivatives
12/08/2004	CN1178931C Substituted pyrazole compounds
12/08/2004	CN1178927C Histamine H3 receptor ligands
12/08/2004	CN1178922C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
12/08/2004	CN1178921C Preparation of sulfonamides
12/08/2004	CN1178917C N-oxides as NK1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
12/08/2004	CN1178912C Small molecule inhibitors of rotamase enzyme activity
12/08/2004	CN1178911C Pyrrolidine and piperidine derivatives and their use for treatment of neurodegenerative disorders
12/08/2004	CN1178906C N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
12/08/2004	CN1178905C Novel peptide derivative
12/08/2004	CN1178889C Polyhydroxyphenol derivatives and preventive and therapeutic agents for bone and cartilage diseases containing the same
12/08/2004	CN1178694C Use of IL-12 and IFN-'alpha' for treatment of infectiong diseases

1 ... 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 ... 1564